Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Rudick

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 17, 2017
The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosisPeter Feys, Ilse Lamers, Gordon Francis, et al.
Annals of Neurology|April 29, 2008
Imaging correlates of decreased axonal Na+/K+ ATPase in chronic multiple sclerosis lesionsElizabeth A Young, Christie D Fowler, Grahame J Kidd, et al.
Brain : a Journal of Neurology|September 28, 2007
Activation of the ciliary neurotrophic factor (CNTF) signalling pathway in cortical neurons of multiple sclerosis patientsRanjan Dutta, Jennifer McDonough, Ansi Chang, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 13, 2022
Real-world effectiveness of dimethyl fumarate versus fingolimod in a cohort of patients with multiple sclerosis using standardized, quantitative outcome metricsCarrie M Hersh, Arman Altincatal, Nicholas Belviso, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 17, 2017
Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosisLaura J Balcer, Jenelle Raynowska, Rachel Nolan, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 12, 2014
Commonalities and challenges in the development of clinical trial measures in neurologyJesse M Cedarbaum, Diane Stephenson, Richard Rudick, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 23, 2015
Erratum to: Commonalities and Challenges in the Development of Clinical Trial Measures in NeurologyJesse M Cedarbaum, Diane Stephenson, Richard Rudick, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 13, 2017
Processing speed test: Validation of a self-administered, iPad<sup>®</sup>-based tool for screening cognitive dysfunction in a clinic settingStephen M Rao, Genna Losinski, Lyla Mourany, et al.
Multiple Sclerosis and Related Disorders|October 26, 2022
Benefits of early treatment with natalizumab: a real-world studyDaniel Ontaneda, Ellen M Mowry, Scott D Newsome, et al.
Annals of Neurology|January 5, 2006
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patientsRanjan Dutta, Jennifer McDonough, Xinghua Yin, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 17, 2017
The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosisPeter Feys, Ilse Lamers, Gordon Francis, et al.
Annals of Neurology|April 29, 2008
Imaging correlates of decreased axonal Na+/K+ ATPase in chronic multiple sclerosis lesionsElizabeth A Young, Christie D Fowler, Grahame J Kidd, et al.
Brain : a Journal of Neurology|September 28, 2007
Activation of the ciliary neurotrophic factor (CNTF) signalling pathway in cortical neurons of multiple sclerosis patientsRanjan Dutta, Jennifer McDonough, Ansi Chang, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 13, 2022
Real-world effectiveness of dimethyl fumarate versus fingolimod in a cohort of patients with multiple sclerosis using standardized, quantitative outcome metricsCarrie M Hersh, Arman Altincatal, Nicholas Belviso, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 17, 2017
Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosisLaura J Balcer, Jenelle Raynowska, Rachel Nolan, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 12, 2014
Commonalities and challenges in the development of clinical trial measures in neurologyJesse M Cedarbaum, Diane Stephenson, Richard Rudick, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 23, 2015
Erratum to: Commonalities and Challenges in the Development of Clinical Trial Measures in NeurologyJesse M Cedarbaum, Diane Stephenson, Richard Rudick, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 13, 2017
Processing speed test: Validation of a self-administered, iPad<sup>®</sup>-based tool for screening cognitive dysfunction in a clinic settingStephen M Rao, Genna Losinski, Lyla Mourany, et al.
Multiple Sclerosis and Related Disorders|October 26, 2022
Benefits of early treatment with natalizumab: a real-world studyDaniel Ontaneda, Ellen M Mowry, Scott D Newsome, et al.
Annals of Neurology|January 5, 2006
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patientsRanjan Dutta, Jennifer McDonough, Xinghua Yin, et al.
Pageof 3